The contribution of the enzymes CYP2D6 and CYP2C19 in the demethylation of artemether in healthy subjects.
- 1 September 1998
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Drug Metabolism and Pharmacokinetics
- Vol. 23 (3), 429-436
- https://doi.org/10.1007/bf03192305
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Single dose pharmacokinetics of oral artemether in healthy Malaysian volunteersBritish Journal of Clinical Pharmacology, 1997
- Clinical Pharmacology and Therapeutic Potential of Artemisinin and its Derivatives in the Treatment of MalariaDrugs, 1996
- Comparative bioavailability of oral, rectal, and intramuscular artemether in healthy subjects: use of simultaneous measurement by high performance liquid chromatography and bioassayBritish Journal of Clinical Pharmacology, 1996
- Dissolution testing of artemisinin solid oral dosage formsInternational Journal of Pharmaceutics, 1996
- The role of cytochrome P450 enzymes in hepatic and extrahepatic human drug toxicityPharmacology & Therapeutics, 1995
- Geographical/Interracial Differences in Polymorphic Drug OxidationClinical Pharmacokinetics, 1995
- The development and spread of drug-resistant malariaParasitology Today, 1991
- Metabolism of antimalarial sesquiterpene lactonesPharmacology & Therapeutics, 1990
- The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; an explanation for the double peak phenomenonJournal of Pharmacokinetics and Biopharmaceutics, 1987
- Qinghaosu (Artemisinin): an Antimalarial Drug from ChinaScience, 1985